Bionano Genomics (BNGO) Other Accumulated Expenses (2024 - 2026)

Bionano Genomics' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $458000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $458000.0; the TTM figure through Mar 2026 stood at $458000.0 (changed N/A YoY), while the FY2025 annual figure was $499000.0, up 3018.75% from the prior year.
• Other Accumulated Expenses came in at $458000.0 for Q1 2026 at Bionano Genomics, down from $499000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $499000.0 in Q4 2025 to a low of $16000.0 in Q4 2024.
• A 3-year average of $324333.3 and a median of $458000.0 in 2026 frame the typical range for Other Accumulated Expenses.
• On a YoY basis, Other Accumulated Expenses climbed as much as 3018.75% in 2025 and fell as far as 3018.75% in 2025.
• Bionano Genomics' Other Accumulated Expenses stood at $16000.0 in 2024, then jumped by 3018.75% to $499000.0 in 2025, then slipped by 8.22% to $458000.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $458000.0, $499000.0, and $16000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison